Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

Hundreds of people have reported problems with their pancreas linked to taking weight loss and diabetes jabs, prompting ...

This innovation is led by the need for greater patient compliance and user-friendliness, portending an era of more convenient ...

Orfoglipron was associated with improved glycemic control and weight reduction among patients with early-stage type 2 diabetes.

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

A new study has been launched into the side effects of weight loss and diabetes jabs after hundreds of cases of pancreatitis ...

A comprehensive review of nearly 150 studies reveals that coffee polyphenols may help regulate blood sugar and reduce ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...